AAD
  • Registration
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Topics
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Resources
  • Registration
Facebook iconInstagram iconTwitter icon
Jul 22, 2022

Laser focused

Expanding therapy for patients with hidradenitis suppurativa.


So Yeon Paek, MD, FAAD
So Yeon Paek, MD, FAAD

P012 – New and Emerging Therapies
Friday, July 22 | 1-3 p.m.
Room 211

Dermatology is taking a fresh look into expanding existing surgical and laser interventions for the management of hidradenitis suppurativa (HS). This afternoon’s session, P012 – New and Emerging Therapies offers hope to the many patients living with the painful lumps deep in their skin. 

So Yeon Paek, MD, FAAD, assistant clinical professor of dermatology at Texas A&M College of Medicine in Dallas leads the session, which will detail surgical options for general dermatologists to use in their daily practice. Existing HS surgical therapies include traditional de-roofing, local and wide excisions, and STEEP (skin-tissue-saving excision with electrosurgical peeling). 

New MODES for treatment

During the session, Dr. Paek will introduce a novel outpatient procedure called MODES (MOdified Deroofing with Exploratory sinus tract and Scar excision). She will take attendees through step-by-step video instructions for performing the MODES outpatient procedure in their own offices.

“In recent years, developments have been made in the medical treatment of HS, but none are capable of dissolving scar tissue, or the epithelial linings present in chronic sinuses,” Dr. Paek said. “The benefits of a combined medical-surgical approach to treating HS offer patients surgical procedures that may be performed by dermatologists in their offices and may elevate patients’ quality of life and treatment satisfaction with concurrent medical therapy for this difficult-to-treat disease.”

“Our MODES technique is unique in that it combines both an initial de-roofing procedure, followed by exploration and subsequent marsupialization and excision of involved scar tissue,” Dr. Paek said. “We have performed this procedure in a large cohort of patients with great success. Our technique accomplishes many of the key goals in the surgical treatment of HS, including early disease management, reduction of chronic pain, prevention of morbidity, significant tissue loss, recurrent procedures, and prolonged hospital stays.”

The session will encourage a combined surgical and medical approach to treating HS, and will also explore various laser devices and procedures that may be used to treat it. Iltefat Hamzavi, MD, FAAD, a dermatologist at Henry Ford Hospital department of dermatology and Wayne State University in Detroit, will provide a comprehensive review of the Nd:YAG, CO₂ laser, and IPL with radiofrequency devices, among other laser therapies for HS.

Visit AAD DermWorld Meeting News Central for more articles.

Interesting Stories
Advancing Therapeutic Conversations
Presented by AbbVie
Advancing Therapeutic Conversations
Join Us to Learn More About SOTYKTU<sup>TM</sup> (deucravacitinib):
Presented by Bristol Myers Squibb
Join Us to Learn More About SOTYKTUTM (deucravacitinib):
Janssen-Sponsored Symposium
Presented by Janssen Biotech, Inc.
Janssen-Sponsored Symposium
What makes a biosimilar and an Interchangeable biosimilar different?
Presented by Boehringer Ingelheim
What makes a biosimilar and an Interchangeable biosimilar different?
Beyond the Scalp: Deciphering the Complexities of Alopecia Areata...
Presented by Pfizer Inc.
Beyond the Scalp: Deciphering the Complexities of Alopecia Areata...
Residents and Young Physicians: Your Guide to the AAD Annual Meeting
Presented by Neutrogena
Residents and Young Physicians: Your Guide to the AAD Annual Meeting
Prurigo Nodularis and Atopic Dermatitis:
Presented by Sanofi and Regeneron Pharmaceuticals, Inc.
Prurigo Nodularis and Atopic Dermatitis:
More in 2022 AAD Innovation Academy
Keira L. Barr, MD, FAAD
2022 AAD Innovation Academy
Unlocking the secrets of mind-body therapy
Jul 29, 2022
Robert T. Brodell, MD, FAAD
2022 AAD Innovation Academy
Fox Lecture: Access belongs to everyone
Jul 29, 2022
Img 9508
2022 AAD Innovation Academy
AAD debuts Innovation Academy in Vancouver
Jul 29, 2022
Edit Olasz Harken, MD, PhD, FAAD
2022 AAD Innovation Academy
Your name can be your skin care brand
Jul 29, 2022
Pearl E. Grimes, MD, FAAD
2022 AAD Innovation Academy
Kelly Lectureship traces advances in pigmentary diseases
Jul 29, 2022
Pearl Grimes, MD, FAAD, and Robert T. Brodell, MD, FAAD, FRCP
2022 AAD Innovation Academy
Saturday’s named lectureships take the stage
Jul 23, 2022
Jason B. Lee, MD, FAAD
2022 AAD Innovation Academy
How are your diagnostic skills?
Jul 23, 2022
Lindsay Strowd, MD, FAAD
2022 AAD Innovation Academy
Consultive dermatology plugs in post pandemic
Jul 23, 2022
Mehdi Rashighi, MD, FAAD
2022 AAD Innovation Academy
Game-changing new treatments evolve for dermatologic conditions
Jul 23, 2022
Carolyn Goh, MD, FAAD
2022 AAD Innovation Academy
New approaches to managing hair disorders
Jul 23, 2022
Brett A. King, MD, PhD, FAAD
2022 AAD Innovation Academy
JAK inhibitors revolutionize dermatology
Jul 22, 2022
Ascend Derm Tank Graphic2
2022 AAD Innovation Academy
Dive into the excitement of Derm Tank!
Jul 22, 2022
AAD
Facebook iconInstagram iconTwitter icon
© Ascend Media All rights reserved. DermWorld Meeting News Central is a publication of the American Academy of Dermatology.